UK Companies House feature
STIRLING ANGLIAN PHARMACEUTICALS LIMITED
Cash
£652K
-3.5% vs 2020
Net assets
£880K
+220.5% vs 2020
Employees
4
0% vs 2020
Profit before tax
—
Period ending 2021-12-31
Profile
- Company number
- SC453258
- Status
- Active
- Incorporation
- 2013-06-26
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 86900
- Hubs
- UK Healthcare
Net assets
3-year trend · vs UK Healthcare median
Accounts
3-year trend · latest 2021-12-31
| Metric | Trend | 2019-12-31 | 2020-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Turnover | — | — | — | |
| Operating profit | — | — | — | |
| Profit before tax | — | — | — | |
| Net profit | — | — | — | |
| Cash | £132,051 | £675,633 | £651,800 | |
| Total assets less current liabilities | £272,450 | £152,669 | £1,869,144 | |
| Net assets | -£1,117,674 | -£730,228 | £879,976 | |
| Equity | -£1,117,674 | -£730,228 | £879,976 | |
| Average employees | 4 | 4 | 4 | |
| Wages | — | — | — |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors are of the opinion that the company can meet its obligations as they fall due for the foreseeable future. The company has a healthy net assets position and a positive bank balance. The directors have prepared budgets and cash flow projections that show the company will be profitable for the foreseeable future. On this basis, the directors consider it appropriate to prepare the financial statements on the going concern basis.”
Subsidiaries
- Kelso Pharma Ireland Limited · 100% held · Ireland · Dormant
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
4 active · 10 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| INKER, Mark Charles | Director | 2023-02-20 | Jun 1964 | British |
| KING, Alan Fernie | Director | 2025-07-29 | Aug 1973 | British |
| MCLEAN, Andrew Firth | Director | 2021-12-21 | Aug 1965 | British |
| STRATFORD, Harry Thomas, Dr | Director | 2021-12-21 | Nov 1970 | British |
Show 10 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ALSOP, Matthew Robert | Director | 2013-10-09 | 2016-10-13 |
| COOK, Mark | Director | 2013-10-09 | 2021-12-21 |
| FARQUHARSON, Carol Ann | Director | 2014-01-31 | 2017-01-04 |
| MCMENEMY, Philip, Dr | Director | 2013-10-09 | 2016-09-05 |
| NEUMAIER, Gerhard Wilhelm | Director | 2014-07-15 | 2017-07-14 |
| PERRIE, Sean Ambrose | Director | 2013-06-26 | 2021-12-21 |
| SCULLION, Stephen Peter | Director | 2015-02-01 | 2016-10-14 |
| THORBURN, Alastair | Director | 2013-10-09 | 2014-12-31 |
| WATSON, Allan Mark | Director | 2021-12-21 | 2025-07-28 |
| WESTAWAY, Karen Mary | Director | 2013-10-09 | 2015-04-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Kelso International Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-12-21 | Active |
| Mr Sean Ambrose Perrie | Individual | Shares 50–75% | 2016-04-06 | Ceased 2021-12-21 |
Filing timeline
Last 20 of 85 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-08-12 | AA | accounts | accounts with accounts type full |
| 2025-07-30 | AP01 | officers | appoint person director company with name date |
| 2025-07-30 | TM01 | officers | termination director company with name termination date |
| 2025-07-10 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-02-24 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2025-02-18 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2025-01-31 | MR04 | mortgage | mortgage satisfy charge full |
| 2024-10-07 | AA | accounts | accounts with accounts type full |
| 2024-07-10 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-04-02 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2023-08-08 | AA | accounts | accounts with accounts type small |
| 2023-07-06 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-05-02 | AD02 | address | change sail address company with old address new address |
| 2023-02-21 | AP01 | officers | appoint person director company with name date |
| 2022-09-29 | AA | accounts | accounts with accounts type unaudited abridged |
| 2022-08-05 | CS01 | confirmation-statement | confirmation statement with updates |
| 2022-01-19 | AD03 | address | move registers to sail company with new address |
| 2022-01-19 | AD02 | address | change sail address company with new address |
| 2022-01-19 | MA | incorporation | memorandum articles |
| 2022-01-19 | RESOLUTIONS | resolution | resolution |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Composite activity score · components 0–100 · reference 2026-05-10
40.8
COOL
/ 100
- Filings velocity 33
- Capital events 0
- Officer churn 50
- Headcount trajectory 50
- Accounts trajectory 100
- 4 filing(s) in last 12 months
- 1 appointed, 1 resigned (12mo)
- Employees +0% YoY
- Net Assets +221% YoY